30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Healthcare Equipment & Supplies

Health Catalyst Inc (HCAT)

Track

Over the last 90 days, Health Catalyst Inc. has seen 6 insider transactions, all of which were proposed sales totaling $115,537.02. No insider purchases were recorded. This activity occurred following a recent earnings report where the company beat expectations by 100%. The stock has seen a 21.2% increase in the last 90 days.
Stock chart
Ticker: HCAT Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Benjamin Albert
Officer
1 sale — total 100,000 USD
Proposed sale 10 Jun 2026
Value US$222,330.84 | Price 494.25 | Shares 25,443
Proposed sale 1 Jun 2026
Value US$2,080,764.82 | Price 276.58 | Shares 39,734
Proposed sale 1 Jun 2026
Value US$18,879.99 | Price 1.37 | Shares 13,779
Proposed sale 1 Jun 2026
Value US$11,672.73 | Price 1.37 | Shares 8,519
Proposed sale 1 Jun 2026
Value US$460.39 | Price 1.37 | Shares 336
Proposed sale 1 May 2026
Value US$416.95 | Price 1.35 | Shares 310
Proposed sale 10 Mar 2026
Value US$130,207.89 | Price 1.85 | Shares 70,455
Proposed sale 2 Mar 2026
Value US$44,767.50 | Price 1.66 | Shares 26,970
Proposed sale 2 Mar 2026
Value US$22,966.38 | Price 1.66 | Shares 13,836
Proposed sale 2 Mar 2026
Value US$42,817.12 | Price 1.66 | Shares 25,795
Proposed sale 2 Mar 2026
Value US$8,243.06 | Price 1.66 | Shares 4,966
Proposed sale 2 Mar 2026
Value US$34,589.00 | Price 1.66 | Shares 20,838
Proposed sale 2 Mar 2026
Value US$26,103.59 | Price 1.66 | Shares 15,726
Proposed sale 26 Feb 2026
Value US$11,040.85 | Price 1.75 | Shares 6,317
Proposed sale 26 Feb 2026
Value US$23,252.73 | Price 1.75 | Shares 13,304
Proposed sale 26 Feb 2026
Value US$11,559.95 | Price 1.75 | Shares 6,614
Proposed sale 26 Feb 2026
Value US$13,146.95 | Price 1.75 | Shares 7,522
Proposed sale 26 Feb 2026
Value US$50,467.72 | Price 1.75 | Shares 28,875
Proposed sale 26 Feb 2026
Value US$7,814.41 | Price 1.75 | Shares 4,471
Planned sale 5 Dec 2025
Value US$72,327.95 | Price 2.64 | Shares 27,425
Proposed sale 5 Dec 2025
Value US$73,773.25 | Price 2.69 | Shares 27,425
Sale 4 Dec 2025
Value US$128,348.78 | Price 2.67 | Shares 47,997
Proposed sale 4 Dec 2025
Value US$128,343.98 | Price 2.67 | Shares 47,997
Proposed sale 1 Dec 2025
Value US$13,900.66 | Price 2.90 | Shares 4,793
Proposed sale 1 Dec 2025
Value US$28,311.25 | Price 2.90 | Shares 9,762
Proposed sale 1 Dec 2025
Value US$59,799.22 | Price 2.90 | Shares 20,619
Proposed sale 1 Dec 2025
Value US$47,566.18 | Price 2.90 | Shares 16,401
Proposed sale 1 Dec 2025
Value US$161,584.64 | Price 2.90 | Shares 55,715
Proposed sale 1 Dec 2025
Value US$41,725.18 | Price 2.90 | Shares 14,387
Planned sale 5 Sep 2025
Value US$20,704.78 | Price 3.35 | Shares 6,175
Proposed sale 5 Sep 2025
Value US$20,377.50 | Price 3.30 | Shares 6,175
Proposed sale 2 Sep 2025
Value US$9,597.15 | Price 3.36 | Shares 2,854
Proposed sale 2 Sep 2025
Value US$15,394.44 | Price 3.36 | Shares 4,578
Proposed sale 2 Sep 2025
Value US$10,552.15 | Price 3.36 | Shares 3,138
Proposed sale 2 Sep 2025
Value US$8,786.74 | Price 3.36 | Shares 2,613
Proposed sale 2 Sep 2025
Value US$28,028.10 | Price 3.36 | Shares 8,335
Proposed sale 2 Sep 2025
Value US$11,298.67 | Price 3.36 | Shares 3,360
Proposed sale 2 Sep 2025
Value US$12,317.57 | Price 3.36 | Shares 3,663
Planned sale 5 Jun 2025
Value US$23,890.63 | Price 3.94 | Shares 6,057
Proposed sale 5 Jun 2025
Value US$23,925.15 | Price 3.95 | Shares 6,057
Proposed sale 2 Jun 2025
Value US$11,831.27 | Price 3.63 | Shares 3,255
Proposed sale 2 Jun 2025
Value US$17,254.40 | Price 3.63 | Shares 4,747
Proposed sale 2 Jun 2025
Value US$13,819.51 | Price 3.63 | Shares 3,802
Proposed sale 2 Jun 2025
Value US$10,777.18 | Price 3.63 | Shares 2,965
Proposed sale 2 Jun 2025
Value US$9,857.58 | Price 3.63 | Shares 2,712
Proposed sale 2 Jun 2025
Value US$31,470.10 | Price 3.63 | Shares 8,658
Planned sale 5 May 2025
Value US$21,331.38 | Price 4.10 | Shares 5,209
Planned sale 3 Apr 2025
Value US$21,604.33 | Price 4.15 | Shares 5,209
Proposed sale 3 Apr 2025
Value US$46,360.10 | Price 4.45 | Shares 10,418
Planned sale 6 Mar 2025
Value US$62,860.31 | Price 4.55 | Shares 13,827
Proposed sale 6 Mar 2025
Value US$62,912.85 | Price 4.55 | Shares 13,827
Planned sale 5 Mar 2025
Value US$76,331.12 | Price 4.52 | Shares 16,902
Proposed sale 5 Mar 2025
Value US$76,397.04 | Price 4.52 | Shares 16,902
Proposed sale 3 Mar 2025
Value US$154,143.00 | Price 4.58 | Shares 33,677
Proposed sale 3 Mar 2025
Value US$34,442.68 | Price 4.58 | Shares 7,525
Proposed sale 3 Mar 2025
Value US$41,303.75 | Price 4.58 | Shares 9,024
Proposed sale 3 Mar 2025
Value US$49,432.68 | Price 4.58 | Shares 10,800
Proposed sale 3 Mar 2025
Value US$33,431.14 | Price 4.58 | Shares 7,304
Proposed sale 3 Mar 2025
Value US$42,255.79 | Price 4.58 | Shares 9,232
Planned sale 18 Feb 2025
Value US$34,952.73 | Price 5.43 | Shares 6,441
Proposed sale 18 Feb 2025
Value US$35,994.22 | Price 5.42 | Shares 6,641
Planned sale 5 Feb 2025
Value US$30,007.49 | Price 5.76 | Shares 5,209
Proposed sale 5 Feb 2025
Value US$29,274.58 | Price 5.62 | Shares 5,209
Planned sale 15 Jan 2025
Value US$37,348.14 | Price 5.80 | Shares 6,442
Proposed sale 15 Jan 2025
Value US$38,007.80 | Price 5.90 | Shares 6,442
Planned sale 6 Jan 2025
Value US$39,134.18 | Price 7.51 | Shares 5,209
Planned sale 6 Jan 2025
Value US$18,795.50 | Price 7.52 | Shares 2,500
Proposed sale 6 Jan 2025
Value US$18,550.00 | Price 7.42 | Shares 2,500
Proposed sale 6 Jan 2025
Value US$38,650.78 | Price 7.42 | Shares 5,209
Planned sale 30 Dec 2024
Value US$31,184.10 | Price 6.93 | Shares 4,500
Proposed sale 30 Dec 2024
Value US$31,860.00 | Price 7.08 | Shares 4,500
Planned sale 23 Dec 2024
Value US$31,415.40 | Price 6.98 | Shares 4,500
Proposed sale 23 Dec 2024
Value US$31,905.00 | Price 7.09 | Shares 4,500
Planned sale 16 Dec 2024
Value US$50,793.88 | Price 7.88 | Shares 6,442
Proposed sale 16 Dec 2024
Value US$51,471.58 | Price 7.99 | Shares 6,442
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-10 2026-06-10 PrS Proposed sale
Benjamin Albert

Officer

Officer
25,443
494.25
US$222,331 		25,443 494.25 US$222,331
2026-06-01 2026-06-01 PrS Proposed sale
Jason Alger

Officer

Officer
39,734
276.58
US$2,080,765 		39,734 276.58 US$2,080,765
2026-06-01 2026-06-01 PrS Proposed sale
Benjamin Landry

Officer

Officer
19,415
95.72
US$4,572,357 		19,415 95.72 US$4,572,357
2026-06-01 2026-06-01 PrS Proposed sale
Linda Llewelyn

Officer

Officer
8,519
1.37
US$11,673 		8,519 1.37 US$11,673
2026-06-01 2026-06-01 PrS Proposed sale
Benjamin Albert

Officer

Officer
336
1.37
US$460 		336 1.37 US$460
2026-05-01 2026-05-01 PrS Proposed sale
Benjamin Albert

Officer

Officer
310
1.35
US$417 		310 1.35 US$417
2026-03-10 2026-03-10 PrS Proposed sale
Benjamin Albert

Officer

Officer
70,455
1.85
US$130,208 		70,455 1.85 US$130,208
2026-03-02 2026-03-02 PrS Proposed sale
Jason Alger

Officer

Officer
26,970
1.66
US$44,768 		26,970 1.66 US$44,768
2026-03-02 2026-03-02 PrS Proposed sale
Linda Llewelyn

Officer

Officer
13,836
1.66
US$22,966 		13,836 1.66 US$22,966
2026-03-02 2026-03-02 PrS Proposed sale
2.8
Daniel Burton

Other
25,795
1.66
US$42,817 		25,795 1.66 US$42,817
2026-03-02 2026-03-02 PrS Proposed sale
Benjamin Albert

Officer

Officer
4,966
1.66
US$8,243 		4,966 1.66 US$8,243
2026-03-02 2026-03-02 PrS Proposed sale
Benjamin Landry

Officer

Officer
20,838
1.66
US$34,589 		20,838 1.66 US$34,589
2026-03-02 2026-03-02 PrS Proposed sale
Kevin Freeman

Other
15,726
1.66
US$26,104 		15,726 1.66 US$26,104
2026-02-26 2026-02-26 PrS Proposed sale
Benjamin Landry

Officer

Officer
6,317
1.75
US$11,041 		6,317 1.75 US$11,041
2026-02-26 2026-02-26 PrS Proposed sale
Benjamin Albert

Officer

Officer
13,304
1.75
US$23,253 		13,304 1.75 US$23,253
2026-02-26 2026-02-26 PrS Proposed sale
Kevin Freeman

Other
6,614
1.75
US$11,560 		6,614 1.75 US$11,560
2026-02-26 2026-02-26 PrS Proposed sale
Jason Alger

Officer

Officer
7,522
1.75
US$13,147 		7,522 1.75 US$13,147
2026-02-26 2026-02-26 PrS Proposed sale
2.8
Daniel Burton

Other
28,875
1.75
US$50,468 		28,875 1.75 US$50,468
2026-02-26 2026-02-26 PrS Proposed sale
Linda Llewelyn

Officer

Officer
4,471
1.75
US$7,814 		4,471 1.75 US$7,814
2025-12-09 2025-12-05 PlS Planned sale
Landry Benjamin

General Counsel

Officer
27,425 -21.5%
2.64
US$72,328 		27,425 -21.5% 2.64 US$72,328
2025-12-05 2025-12-05 PrS Proposed sale
BENJAMIN LANDRY

Officer

Officer
27,425
2.69
US$73,773 		27,425 2.69 US$73,773
2025-12-09 2025-12-04 S Sale
3.2
Larson-Green Julie
Non-Executive Director
47,997 -39.5%
2.67
US$128,349 		47,997 -39.5% 2.67 US$128,349
2025-12-04 2025-12-04 PrS Proposed sale
3.2
JULIE LARSON-GREEN

Director

Non-Executive Director
47,997
2.67
US$128,344 		47,997 2.67 US$128,344
2025-12-01 2025-12-01 PrS Proposed sale
David Ross

Officer

Officer
4,793
2.90
US$13,901 		4,793 2.90 US$13,901
2025-12-01 2025-12-01 PrS Proposed sale
Linda Llewellyn

Officer

Officer
9,762
2.90
US$28,311 		9,762 2.90 US$28,311
2025-12-01 2025-12-01 PrS Proposed sale
Jason Alger

Officer

Officer
20,619
2.90
US$59,799 		20,619 2.90 US$59,799
2025-12-01 2025-12-01 PrS Proposed sale
Kevin Freeman

Officer

Officer
16,401
2.90
US$47,566 		16,401 2.90 US$47,566
2025-12-01 2025-12-01 PrS Proposed sale
2.8
Daniel Burton

Officer

Officer
55,715
2.90
US$161,585 		55,715 2.90 US$161,585
2025-12-01 2025-12-01 PrS Proposed sale
Benjamin Landry

Officer

Officer
14,387
2.90
US$41,725 		14,387 2.90 US$41,725
2025-09-09 2025-09-05 PlS Planned sale
Landry Benjamin

General Counsel

Officer
6,175 -4.2%
3.35
US$20,705 		6,175 -4.2% 3.35 US$20,705
2025-09-05 2025-09-05 PrS Proposed sale
BENJAMIN LANDRY

Officer

Officer
6,175
3.30
US$20,378 		6,175 3.30 US$20,378
2025-09-02 2025-09-02 PrS Proposed sale
Linda Llewelyn

Officer

Officer
2,854
3.36
US$9,597 		2,854 3.36 US$9,597
2025-09-02 2025-09-02 PrS Proposed sale
Kevin Freeman

Officer

Officer
4,578
3.36
US$15,394 		4,578 3.36 US$15,394
2025-09-02 2025-09-02 PrS Proposed sale
Benjamin Landry

Officer

Officer
3,138
3.36
US$10,552 		3,138 3.36 US$10,552
2025-09-02 2025-09-02 PrS Proposed sale
Jason Alger

Officer

Officer
2,613
3.36
US$8,787 		2,613 3.36 US$8,787
2025-09-02 2025-09-02 PrS Proposed sale
2.8
Daniel Burton

Officer

Officer
8,335
3.36
US$28,028 		8,335 3.36 US$28,028
2025-09-02 2025-09-02 PrS Proposed sale
David Ross

Officer

Officer
3,360
3.36
US$11,299 		3,360 3.36 US$11,299
2025-09-02 2025-09-02 PrS Proposed sale
Daniel LeSueur

Officer

Officer
3,663
3.36
US$12,318 		3,663 3.36 US$12,318
2025-06-09 2025-06-05 PlS Planned sale
Landry Benjamin

General Counsel

Officer
6,057 -3.9%
3.94
US$23,891 		6,057 -3.9% 3.94 US$23,891
2025-06-05 2025-06-05 PrS Proposed sale
BENJAMIN LANDRY

Officer

Officer
6,057
3.95
US$23,925 		6,057 3.95 US$23,925
2025-06-02 2025-06-02 PrS Proposed sale
Benjamin Landry

Officer

Officer
3,255
3.63
US$11,831 		3,255 3.63 US$11,831
2025-06-02 2025-06-02 PrS Proposed sale
Kevin Freeman

Officer

Officer
4,747
3.63
US$17,254 		4,747 3.63 US$17,254
2025-06-02 2025-06-02 PrS Proposed sale
Daniel LeSueur

Officer

Officer
3,802
3.63
US$13,820 		3,802 3.63 US$13,820
2025-06-02 2025-06-02 PrS Proposed sale
Linda Llewelyn

Officer

Officer
2,965
3.63
US$10,777 		2,965 3.63 US$10,777
2025-06-02 2025-06-02 PrS Proposed sale
Jason Alger

Officer

Officer
2,712
3.63
US$9,858 		2,712 3.63 US$9,858
2025-06-02 2025-06-02 PrS Proposed sale
2.8
Daniel Burton

Officer

Officer
8,658
3.63
US$31,470 		8,658 3.63 US$31,470
2025-05-07 2025-05-05 PlS Planned sale
LeSueur Daniel

Chief Operating Officer

Officer
5,209 -2.5%
4.10
US$21,331 		5,209 -2.5% 4.10 US$21,331
2025-04-07 2025-04-03 PlS Planned sale
LeSueur Daniel

Chief Operating Officer

Officer
5,209 -2.4%
4.15
US$21,604 		5,209 -2.4% 4.15 US$21,604
2025-04-03 2025-04-03 PrS Proposed sale
DANIEL LESUEUR

Officer

Officer
10,418
4.45
US$46,360 		10,418 4.45 US$46,360
2025-03-10 2025-03-06 PlS Planned sale
Landry Benjamin

General Counsel

Officer
13,827 -7.9%
4.55
US$62,860 		13,827 -7.9% 4.55 US$62,860
2025-03-06 2025-03-06 PrS Proposed sale
BENJAMIN LANDRY

Officer

Officer
13,827
4.55
US$62,913 		13,827 4.55 US$62,913
2025-03-10 2025-03-05 PlS Planned sale
LeSueur Daniel

Chief Operating Officer

Officer
16,902 -7.2%
4.52
US$76,331 		16,902 -7.2% 4.52 US$76,331
2025-03-05 2025-03-05 PrS Proposed sale
DANIEL LESUEUR

Officer

Officer
16,902
4.52
US$76,397 		16,902 4.52 US$76,397
2025-03-03 2025-03-03 PrS Proposed sale
2.8
Daniel Burton

Officer

Officer
33,677
4.58
US$154,143 		33,677 4.58 US$154,143
2025-03-03 2025-03-03 PrS Proposed sale
Linda Llewelyn

Officer

Officer
7,525
4.58
US$34,443 		7,525 4.58 US$34,443
2025-03-03 2025-03-03 PrS Proposed sale
Benjamin Landry

Officer

Officer
9,024
4.58
US$41,304 		9,024 4.58 US$41,304
2025-03-03 2025-03-03 PrS Proposed sale
Kevin Freeman

Officer

Officer
10,800
4.58
US$49,433 		10,800 4.58 US$49,433
2025-03-03 2025-03-03 PrS Proposed sale
Jason Alger

Officer

Officer
7,304
4.58
US$33,431 		7,304 4.58 US$33,431
2025-03-03 2025-03-03 PrS Proposed sale
Daniel LeSueur

Officer

Officer
9,232
4.58
US$42,256 		9,232 4.58 US$42,256
2025-02-20 2025-02-18 PlS Planned sale
Llewelyn Linda

Chief People Officer

Officer
6,441 -7.0%
5.43
US$34,953 		6,441 -7.0% 5.43 US$34,953
2025-02-18 2025-02-18 PrS Proposed sale
LINDA LLEWELYN

Officer

Officer
6,641
5.42
US$35,994 		6,641 5.42 US$35,994
2025-02-06 2025-02-05 PlS Planned sale
LeSueur Daniel

Chief Operating Officer

Officer
5,209 -5.7%
5.76
US$30,007 		5,209 -5.7% 5.76 US$30,007
2025-02-05 2025-02-05 PrS Proposed sale
DANIEL LESUEUR

Officer

Officer
5,209
5.62
US$29,275 		5,209 5.62 US$29,275
2025-01-17 2025-01-15 PlS Planned sale
Llewelyn Linda

Chief People Officer

Officer
6,442 -6.5%
5.80
US$37,348 		6,442 -6.5% 5.80 US$37,348
2025-01-15 2025-01-15 PrS Proposed sale
LINDA LLEWELYN

Officer

Officer
6,442
5.90
US$38,008 		6,442 5.90 US$38,008
2025-01-10 2025-01-06 PlS Planned sale
LeSueur Daniel

Chief Operating Officer

Officer
5,209 -5.4%
7.51
US$39,134 		5,209 -5.4% 7.51 US$39,134
2025-01-10 2025-01-06 PlS Planned sale
Landry Benjamin

General Counsel

Officer
2,500 -3.3%
7.52
US$18,796 		2,500 -3.3% 7.52 US$18,796
2025-01-06 2025-01-06 PrS Proposed sale
BENJAMIN LANDRY

Officer

Officer
2,500
7.42
US$18,550 		2,500 7.42 US$18,550
2025-01-06 2025-01-06 PrS Proposed sale
DANIEL LESUEUR

Officer

Officer
5,209
7.42
US$38,651 		5,209 7.42 US$38,651
2025-01-02 2024-12-30 PlS Planned sale
1.0
Gallagher Duncan
Non-Executive Director
4,500 -6.0%
6.93
US$31,184 		4,500 -6.0% 6.93 US$31,184
2024-12-30 2024-12-30 PrS Proposed sale
1.0
DUNCAN GALLAGHER

Director

Non-Executive Director
4,500
7.08
US$31,860 		4,500 7.08 US$31,860
2024-12-27 2024-12-23 PlS Planned sale
1.0
Gallagher Duncan
Non-Executive Director
4,500 -5.7%
6.98
US$31,415 		4,500 -5.7% 6.98 US$31,415
2024-12-23 2024-12-23 PrS Proposed sale
1.0
DUNCAN GALLAGHER

Director

Non-Executive Director
4,500
7.09
US$31,905 		4,500 7.09 US$31,905
2024-12-18 2024-12-16 PlS Planned sale
Llewelyn Linda

Chief People Officer

Officer
6,442 -6.1%
7.88
US$50,794 		6,442 -6.1% 7.88 US$50,794
2024-12-16 2024-12-16 PrS Proposed sale
LINDA LLEWELYN

Officer

Officer
6,442
7.99
US$51,472 		6,442 7.99 US$51,472
Explore more

More insider trading research around Health Catalyst Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America